Thyroid Cancer
407
86
116
158
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
46 trials with published results (11%)
Research Maturity
158 completed trials (39% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.9%
20 terminated out of 407 trials
88.8%
+2.2% vs benchmark
6%
23 trials in Phase 3/4
29%
46 of 158 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 158 completed trials
Clinical Trials (407)
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
The Use of Candy and Honey in Decreasing Salivary Gland Damage Following Radioiodine Therapy for Thyroid Cancer
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
Mapping Patient Decision-making in Thyroid Cancer
DESTINY-PANTUMOUR04
Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid Cancer
Evaluation of an Artificial Intelligence-enabled Clinical Assistant to Support Thyroid Cancer Management
Effectiveness of WeChat-Supported Neck Rehabilitation Exercises on Early Recovery After Thyroidectomy
Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors
FAPI PET Imaging - An Exploratory Study
Pre-Clinic Visit Online Education for Thyroid Cancer
Project HERO: Health Empowerment & Recovery Outcomes
Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer
Navigation Intervention for Adolescent and Young Adult Cancer Survivors
Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health
The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
Postoperative Hypocalcemia After Thyroidectomy
Integrated Cancer Repository for Cancer Research